AU2002210491A1 - Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof - Google Patents

Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof

Info

Publication number
AU2002210491A1
AU2002210491A1 AU2002210491A AU1049102A AU2002210491A1 AU 2002210491 A1 AU2002210491 A1 AU 2002210491A1 AU 2002210491 A AU2002210491 A AU 2002210491A AU 1049102 A AU1049102 A AU 1049102A AU 2002210491 A1 AU2002210491 A1 AU 2002210491A1
Authority
AU
Australia
Prior art keywords
longlasting
agent
produce
retention time
time used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210491A
Inventor
Gunther Beisel
Rudiger Groning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002210491A1 publication Critical patent/AU2002210491A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/29Mineral substances, e.g. mineral oils or clays
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24Cellulose or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
AU2002210491A 2000-09-11 2001-09-07 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof Abandoned AU2002210491A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10044846A DE10044846A1 (en) 2000-09-11 2000-09-11 Agent with prolonged gastric residence time to produce a long-lasting satiety effect and its use
DE10044846 2000-09-11
PCT/EP2001/010309 WO2002019842A2 (en) 2000-09-11 2001-09-07 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof

Publications (1)

Publication Number Publication Date
AU2002210491A1 true AU2002210491A1 (en) 2002-03-22

Family

ID=7655784

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210491A Abandoned AU2002210491A1 (en) 2000-09-11 2001-09-07 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof

Country Status (7)

Country Link
US (1) US20030161885A1 (en)
EP (1) EP1322182A2 (en)
JP (1) JP2004508310A (en)
AU (1) AU2002210491A1 (en)
CA (1) CA2419389A1 (en)
DE (1) DE10044846A1 (en)
WO (1) WO2002019842A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10247910A1 (en) * 2002-10-14 2004-04-22 Beisel, Günther Oral appetite-suppressant comprises capsule of compressed Konjak meal which is insoluble in gastro-intestinal fluid, but swells in it
EP1572238A1 (en) * 2002-12-19 2005-09-14 Günther Beisel Agent with a retarded release of substances
AU2003294816A1 (en) * 2002-12-19 2004-07-14 Gunther Beisel Preparation for reducing the appetite, producing a satiated feeling and/or for weight loss in children
CN106794143A (en) * 2014-08-11 2017-05-31 佩罗拉股份有限公司 The method of inducing satiety
WO2016023923A1 (en) * 2014-08-11 2016-02-18 Perora Gmbh Formulation comprising particles
CA2989510A1 (en) 2015-07-07 2017-01-12 Perora Gmbh Method of inducing satiety
CA3011287A1 (en) 2016-02-18 2017-08-24 Perora Gmbh Kits comprising satiety-inducing formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3139920A1 (en) * 1981-10-08 1983-04-28 Nittner, Erich, Dr., 8280 Kreuzlingen Agent in the form of granules based on polysaccharide gums, process for the preparation thereof and use
DE3217071A1 (en) * 1982-05-06 1983-11-10 Rüdiger Dr. 6365 Rosbach Gröning Pharmaceutical composition for oral administration with improved bioavailability of the active substances
SE8505569D0 (en) * 1985-11-25 1985-11-25 Aco Laekemedel Ab ENTERAL PREPARATION
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
JPH0451870A (en) * 1990-06-14 1992-02-20 Terumo Corp Anti-obesic food and preparation thereof
DE59710550D1 (en) * 1996-11-27 2003-09-11 Guenther Beisel AGENT FOR PRODUCING A LONG-LASTING SATURATION EFFECT
US5855917A (en) * 1996-12-04 1999-01-05 Wisconsin Alumni Research Foundation Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids
US6054480A (en) * 1997-09-18 2000-04-25 Nectra, Inc. Fatty acids as a diet supplement
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management

Also Published As

Publication number Publication date
DE10044846A1 (en) 2002-04-04
WO2002019842A3 (en) 2007-11-15
JP2004508310A (en) 2004-03-18
EP1322182A2 (en) 2003-07-02
WO2002019842A2 (en) 2002-03-14
US20030161885A1 (en) 2003-08-28
CA2419389A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
MXPA03005923A (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines.
HK1049269A1 (en) Three and five point buckle
EP1347980A4 (en) Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
HUP0301243A3 (en) Herbicidal substituted pyridine-ketones, preparation and use thereof
MXPA03005731A (en) Absorbent article having releasable medicinal treatments.
MXPA02010914A (en) Anthranyl amides and their use as medicaments.
MXPA03004932A (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors.
MXPA03004714A (en) Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents.
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU8420301A (en) Use
HUP0303291A3 (en) Herbicidal composition, preparation and use thereof
AU2001275677A1 (en) 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
GB0026467D0 (en) Compound, composition and use
AU2001235363A1 (en) Mibefradil analogues and their use
AU2002210491A1 (en) Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
IL154675A0 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
AU3956502A (en) Saframycins, analogues and uses thereof
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
GB0005301D0 (en) Compound, composition and use
DE50107204D1 (en) 8BETA-SUBSTITUTED-11BETA-PENTYL AND 11BETA-HEXYL-ESTRA-1,3,5 (10) -TRIENDERIVATE
AU7815201A (en) Synthetic salicylihalamides, apicularens and derivatives thereof
GB0000131D0 (en) Thiolactomycin analogues,compositions containing the same and uses thereof